NODIA METABOLICS

NODIA METABOLICS is developing a dietary supplement based on an innovative ingredient identified by INRAE researchers. The active ingredient's anti-hyperglycemic effects allow to effectively regulate blood sugar levels in pre-diabetic patients and reduce their risk of developing type 2 diabetes. The Start-up has been launched in january 2024 after few years of research at INRAE. The goals of the next few months are to carry out regulatory toxicity testing, to produce initial clinical results and to scale up production for commercialization in 2026.